2023: Another Year Chock Full of Challenges for FDA | Mintz - Health Care Viewpoints
At the start of 2022, we reflected on what the Food and Drug Administration (FDA) had accomplished during the preceding 12 months and the challenges that could be ahead for the agency...
Digital Health Advisory Committee Commerce Committee Radiological Health Mintz Team Clinical Trials Transformation Initiative Manufacturing Technologies Designation Program
Source: jdsupra.com